Rapid Test of Cerebrospinal Fluid Decreases Time to Diagnosis for Brain Tumors
Mass General Brigham
The new rapid genotyping test for brain cancers eliminates the need for invasive biopsies, reducing time to diagnosis from 10 days to 2 days
Brain Tumors
Genetically Engineering a Treatment for Incurable Brain Tumors
Purdue University
Researchers develop fully off-the-shelf, stem cell-derived natural killer cells against glioblastoma
IL-13Rα2-Targeting CAR T-Cell Therapy Improves Brain Cancer
City of Hope
Researchers were able to deliver the CAR-T cells directly into the tumor site and the cerebrospinal fluid
Novel Nanopipette Could Advance Single-Cell Analysis
University of Leeds
Learning how tumor cells adapt to treatment through nanobiopsy could aid in preventing cancer recurrence
Noninvasive Biopsies Help Detect and Monitor Neuroblastoma
Princess Máxima Center for Pediatric Oncology
The simple blood tests for childhood cancers are being tested in the clinical setting for the first time
Combination Therapy Improves Rare Brain Tumors in Children
Great Ormond Street Hospital
Trials showed the effect of combination therapy on survival and quality of life in children with low- and high-grade gliomas
Combo Immunotherapy Trial for Glioblastoma Commences
University of North Carolina School of Medicine
Gene Therapy for Glioblastoma Shows Promise in Phase 1 Trial
Brigham and Women's Hospital
In a first-in-human trial in patients with recurrent glioblastoma, an oncolytic virus treatment safely extended survival
Novel AI Tool Analyses Cancer Cells' Genome During Surgery
Harvard Medical School
Real-time brain tumor profiling can guide surgical and treatment decisions
Combination Therapy May Safely Treat Recurrent Glioblastoma
University of Texas MD Anderson Cancer Center
Study validates the safety of combined delivery of engineered virus with immunotherapy to improve survival rate and quality of life in patients